GRACELL BIOTECHNOLOGIES INC

CUSIP: 38406L103 Class: ADR

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 40,974 Value ($000) $411 Avg Close — Range —
Q3 2023
Shares 16,327 Value ($000) $47 Avg Close — Range —